Attenuation of warm ischemia-reperfusion injury in the liver by bucillamine through decreased neutrophil activation and Bax/Bcl-2 modulation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 12, 2010, Pages 1891-1899

  Junnarkar, Sameer P ^a   Tapuria, Niteen ^a   Mani, Alireza ^a   Dijk, Sas ^a   Fuller, Barry ^a   Seifalian, Alexander M ^a   Davidson, Brian R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antioxidant; Bax; Bcl 2; Bucillamine; Glutathione; Ischemia reperfusion injury; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUCILLAMINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; GLUTATHIONE; ISOPROSTANE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LIVER ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78649618331     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06312.x     Document Type: Article

References (59)

1. Sano M, Fukuda K, Sato T et al. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 2001; 89: 661-9.
2. Ceconi C, Curello S, Albertini A, Ferrari R. Effect of lipid peroxidation on heart mitochondria oxygen consuming and calcium transporting capacities. Mol. Cell. Biochem. 1988; 81: 131-5.
3. Matsuno H, Sugiyama E, Muraguchi A et al. Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs-the disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug. Int. J. Immunopharmacol. 1998; 20: 295-304.
4. Amersi F, Nelson SK, Shen XD et al. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc. Natl. Acad. Sci. USA 2002; 99: 8915-20.
5. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 1652-60.
6. Kohli V, Gao W, Camargo CA Jr, Clavien PA. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc. Natl. Acad. Sci. USA 1997; 94: 9354-9.
7. Kohli V, Madden JF, Bentley RC, Clavien PA. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999; 116: 168-78.
8. Natori S, Selzner M, Valentino KL et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999; 68: 89-96.
9. Bailly-Maitre B, Fondevila C, Kaldas F et al. Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 2006; 103: 2809-14.
10. Ben-Ari Z, Pappo O, Cheporko Y et al. Bax ablation protects against hepatic ischemia/reperfusion injury in transgenic mice. Liver Transpl. 2007; 13: 1181-8.
11. Selzner M, Rudiger HA, Selzner N, Thomas DW, Sindram D, Clavien PA. Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion. J. Hepatol. 2002; 36: 218-25.
12. Zamzami N, Susin SA, Marchetti P et al. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 1996; 183: 1533-44.
13. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc. Res. 2000; 47: 410-18.
14. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 2000; 28: 505-13.
15. Al-Mokdad M, Shibata F, Takano K, Nakagawa H. Differential production of chemokines by phagocytosing rat neutrophils and macrophages. Inflammation 1998; 22: 145-59.
16. Nakagawa H, Komorita N, Shibata F et al. Identification of cytokine-induced neutrophil chemoattractants (CINC), rat GRO/CINC-2 alpha and CINC-2 beta, produced by granulation tissue in culture: purification, complete amino acid sequences and characterization. Biochem. J. 1994; 301 (Pt 2): 545-50.
17. Ramos CD, Heluy-Neto NE, Ribeiro RA, Ferreira SH, Cunha FQ. Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine 2003; 21: 214-23.
18. Shibata F, Shibata Y, Yoshimoto Y, Nakagawa H. The expression of three types of CINCs by lipopolysaccharide-stimulated rat macrophages is inhibited similarly by anti-inflammatory steroids. Inflamm. Res. 2000; 49: 80-5.
19. Suzuki H, Suematsu M, Miura S et al. Rat CINC/gro: a novel mediator for locomotive and secretagogue activation of neutrophils in vivo. J. Leukoc. Biol. 1994; 55: 652-7.
20. Aoki T, Suzuki Y, Nishio K et al. Role of CD18-ICAM-1 in the entrapment of stimulated leukocytes in alveolar capillaries of perfused rat lungs. Am. J. Physiol. 1997; 273 (5 Pt 2): H2361-71.
21. Davenpeck KL, Zagorski J, Schleimer RP, Bochner BS. Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J. Immunol. 1998; 161: 6861-70.
22. Dolecki GJ, Delarco JE. Regulation of cytokine-induced neutrophil chemoattractant (CINC) mRNA production in cultured rat cells. DNA Cell. Biol. 1994; 13: 883-9.
23. Mitsui K, Takano K, Nakatani S, Nambu H, Shibata F, Nakagawa H. Chemokine production by rat macrophages stimulated with streptolysin O from Streptococcus pyogenes. Microbiol. Immunol. 2002; 46: 37-45.
24. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am. J. Pathol. 1994; 145: 1421-31.
25. Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K. Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am. J. Physiol. 1994; 267 (5 Pt 1): G786-93.
26. Vollmar B, Glasz J, Menger MD, Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995; 117: 195-200.
27. Vollmar B, Glasz J, Post S, Menger MD. Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury. J. Surg. Res. 1996; 60: 49-54.
28. Menger MD, Richter S, Yamauchi J, Vollmar B. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 1999; 46 (Suppl. 2): 1452-7.
29. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N. Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology 1992; 15: 507-14.
30. Koti RS, Tsui J, Lobos E, Yang W, Seifalian AM, Davidson BR. Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver. FASEB J. 2005; 19: 1155-7.
31. Wunder C, Brock RW, McCarter SD et al. Inhibition of haem oxygenase activity increases leukocyte accumulation in the liver following limb ischaemia-reperfusion in mice. J. Physiol. 2002; 540 (Pt 3): 1013-21.
32. Croner RS, Hoerer E, Kulu Y et al. Hepatic platelet and leukocyte adherence during endotoxemia. Crit. Care 2006; 10: R15.
33. Oshiro T, Shiraishi M, Muto Y. Adenovirus mediated gene transfer of antiapoptotic protein in hepatic ischemia-reperfusion injury: the paradoxical effect of Bcl-2 expression in the reperfused liver. J. Surg. Res. 2002; 103: 30-6.
34. Tannuri U, Tannuri AC, Coelho MC, Mello ES, Dos Santos AS. Effect of the immunosuppressants on hepatocyte cells proliferation and apoptosis during liver regeneration after hepatectomy-molecular studies. Pediatr. Transplant. 2008; 12: 73-9.
35. Morrow JD, Roberts LJ. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 1999; 300: 3-12.
36. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 1969; 27: 502-22.
37. Suzuki S, Toledo-Pereyra LH. Monoclonal antibody to intercellular adhesion molecule 1 as an effective protection for liver ischemia and reperfusion injury. Transplant. Proc. 1993; 25: 3325-7.
38. Junnarkar SP, Tapuria N, Dutt N, Fuller B, Seifalian AM, Davidson BR. Bucillamine improves hepatic microcirculation and reduces hepatocellular injury following liver warm ischaemia reperfusion injury. HPB 2009; 11: 264-73.
39. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-57.
40. Kane DJ, Ord T, Anton R, Bredesen DE. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 1995; 40: 269-75.
41. Yamabe K, Shimizu S, Kamiike W et al. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem. Biophys. Res. Commun. 1998; 243: 217-23.
42. Altunkan A, Aydin O, Ozer Z, Colak T, Bilgin E, Oral U. Anti-apoptotic effect of succinyl gelatine in a liver ischaemia-reperfusion injury model (Bcl-2, Bax, caspase 3)? Pharmacol. Res. 2002; 45: 485-9.
43. Duenschede F, Westermann S, Miesner I et al. Hepatocellular injury of nonischemic liver tissue after selective clamping in rats-protective action by pharmacological pretreatment with lipoic acid. Eur. Surg. Res. 2007; 39: 325-31.
44. Ishigami F, Naka S, Takeshita K, Kurumi Y, Hanasawa K, Tani T. Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat. Transplantation 2001; 72: 1803-7.
45. Jawan B, Goto S, Pan TL et al. The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver. J. Surg. Res. 2003; 110: 378-82.
46. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H801-6.
47. Jia CJ, Dai CL, Zhang X, Cui K, Xu F, Xu YQ. Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats. World J. Gastroenterol. 2006; 12: 1373-8.
48. Kong R, Gao Y, Sun B et al. The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats. Dig. Dis. Sci. 2009; 54: 2568-76.
49. Wang XH, Wang K, Zhang F et al. Alleviating ischemia-reperfusion injury in aged rat liver by induction of heme oxygenase-1. Transplant. Proc. 2004; 36: 2917-23.
50. Zhang Y, Ye QF, Lu L, Xu XL, Ming YZ, Xiao JS. Panax notoginseng saponins preconditioning protects rat liver grafts from ischemia/reperfusion injury via an antiapoptotic pathway. Hepatobiliary Pancreat. Dis. Int. 2005; 4: 207-12.
51. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 1990; 4: 3355-9.
52. Planaguma A, Titos E, Lopez-Parra M et al. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J. 2002; 16: 1937-9.
53. Matsumura F, Yamaguchi Y, Goto M et al. Xanthine oxidase inhibition attenuates Kupffer cell production of neutrophil chemoattractant following ischemia-reperfusion in rat liver. Hepatology 1998; 28: 1578-87.
54. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 284: G15-26.
55. Accatino L, Pizarro M, Solis N, Arrese M, Koenig CS. Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat. Liver Transpl. 2003; 9: 1199-210.
56. Duenschede F, Erbes K, Riegler N et al. Protective effects of ischemic preconditioning and application of lipoic acid prior to 90 min of hepatic ischemia in a rat model. World J. Gastroenterol. 2007; 13: 3692-8.
57. Dulundu E, Ozel Y, Topaloglu U et al. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats. Pharmacology 2007; 79: 163-70.
58. Wielandt AM, Vollrath V, Farias M, Chianale J. Bucillamine induces glutathione biosynthesis via activation of the transcription factor Nrf2. Biochem. Pharmacol. 2006; 72: 455-62.
59. Kurokawa T, Kobayashi H, Nonami T, Harada A, Nakao A, Takagi H. Mitochondrial glutathione redox and energy producing function during liver ischemia and reperfusion. J. Surg. Res. 1996; 66: 1-5.